Search results
Theravance Biopharma (TBPH) to Sell Trelegy Royalty Interests
Zacks via Yahoo Finance· 2 years agoTheravance Biopharma (TBPH) agrees to sell its Trelegy royalty interests to Royalty Pharma. The...
A Life-long Asthma Patient Shares How She’s Learned to Manage Her Condition
Parade via Yahoo News· 11 months agoRashelle Stocker was diagnosed with asthma in third grade after having her first attack on the...
Theravance Biopharma, Innoviva Gain On Selling TRELEGY ELLIPTA Royalty Interests
Benzinga via Yahoo Finance· 2 years agoTheravance Biopharma, Inc. (NASDAQ: TBPH) has agreed to sell all of its units in Theravance...
GSK Gears Up for Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 2 days agoWe expect GSK's specialty products like Arexvy, Cabenuva, Juluca, Dovato, Nucala, Trelegy Ellipta and Shingrix to drive first-quarter sales performance.
GSK's Q3 Earnings Beat, Ups 2022 Sales Outlook, Stock Up
Zacks via Yahoo Finance· 1 year agoGSK plc GSK reported third-quarter 2022 adjusted earnings of $1.09 per American depositary share...
Royalty Pharma plc (RPRX) Q2 2022 Earnings Call Transcript
Motley Fool· 2 years agoThank you for joining us to review Royalty Pharma's second quarter 2022 results. All forward-looking...
GSK's Key Drugs to Drive Sales in a Sluggish Second Half
Zacks via Yahoo Finance· 2 years agoGSK's specialty products like Dovato, Nucala, Trelegy Ellipta, Shingrix are driving sales, making up...
See price hikes for top 25 drugs covered by Medicare; NJ drugmakers sue to stop change
App.com | Asbury Park Press via Yahoo Finance· 9 months agoAverage prices for 25 widely used drugs covered by Medicare more than tripled since they were...
GSK Gears Up for Q2 Earnings: Will It Surpass Estimates?
Zacks via Yahoo Finance· 9 months agoWe expect GSK plc. GSK to beat expectations when it reports second-quarter 2023 results on Jul 26....
GSK Gears Up to Report Q1 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 1 year agoGSK plc. GSK will report first-quarter 2023 results on Apr 26, before the opening bell. In the last...